Video file


Network and stay on the cutting edge of cardiothoracic surgeryView All >
An opportunity for early and mid-career STS surgeon members to learn how to lead in and out of the OR.
Event dates
Mar 21, 2024 – Jan 23, 2025
Zoom, Chicago, and Los Angeles
Demystify the Oral Board Exam with STS Prep
Event dates
Apr 16 – May 7, 2024
Hands-on team training in robotic mitral valve repair, coronary bypass, and more.
Event dates
May 9–10, 2024
Peachtree Corners, GA

News & Media

The latest from the field of thoracic surgeryView All >
national minority health month

April is National Minority Health Month, a time and opportunity to raise awareness about the importance of improving the health of racial and ethnic minority communities and reducing health disparities. While our patient population in the US is rapidly diversifying, our specialty of cardiothoracic surgery remains one of the least diverse specialties in terms of gender and race.

5 min read
STS Workforce on Diversity, Equity, & Inclusion

In this episode of Same Surgeon, Different Light, Dr. Thomas Varghese talks with Dr. Richard Ohye, the University of Michigan C. S. Mott Children's Hospital Congenital Heart Center, about finding his niche and superpower in cardiothoracic surgery, and how his career has evolved over the years. "When I rotated on pediatrics, it was another level of everything perfect. It was art. This is what I wanted to do. I found my niche," said Dr. Ohye. 

50 mins.

The U.S. Food and Drug Administration (FDA) has issued a Class I recall for nearly 14,000 Abbott and Thoratec HeartMate left ventricular assist devices (LVADs). This recall comes after reports of multiple deaths and injuries associated with these devices, which are used to aid patients with advanced heart failure. 

The recalled devices include: 

  • Product names: HeartMate II and HeartMate 3 Left Ventricular Assist System (LVAS) 
  • Product codes: DSQ 
    • Class 1 Device Recall HeartMate II Left Ventricular Assist System ( 
    • Class 1 Device Recall HeartMate 3 Left Ventricular Assist System ( 
  • Model numbers:  Full List of Affected Devices 
  • Distribution dates: Starting April 21, 2008 

The problem at the center of this recall is the gradual buildup of biological material in these devices develops over 2 or more years, potentially obstructing the device and diminishing its ability to support the heart's pumping action. This issue can trigger alarms for low blood flow and impair the device's effectiveness. 

Recall Action: This recall is classified as a correction rather than a complete product withdrawal. The FDA has not advised the return of all affected devices. However, heightened vigilance concerning low-flow alarms, which may indicate significant outflow obstructions, is recommended. 

Customers should have received an Urgent Medical Device Correction letter on February 19, 2024, providing detailed guidance on monitoring for and addressing potential obstructions. 

Abbott and Thoratec have made efforts to educate physicians on the importance of heeding persistent low-flow alarms as early indicators of potential obstructions and have shared diagnostic recommendations to identify obstructions and discussed treatment options available for managing such issues.  

If you have questions about this recall, contact Abbott and Thoratec directly at (844) 692-6367. To report a problem with these devices, complete the FDA reporting form

Apr 16, 2024
2 min read
STS News Banner
STS News, the Society’s quarterly magazine for members only, brings you the latest CT surgery news, research, stories, and more to help keep you in the know and connected to your peers.

Read the issue

Member Voices

Joseph F. Sabik

Joseph F. Sabik III, MD

STS Second Vice President
It’s about making sure that patients get the right treatment, so they can have the best long-term outcomes.
Africa Wallace, MD

Africa F. Wallace, MD

DEI Workforce Member
Our roles as attendings, division chiefs, chairs, coaches, and mentors come with a larger responsibility.

Robert S.D. Higgins, MD

STS Past President
STS was the first place where I was welcomed to be part of like-minded surgeons focused on patients, who improved outcomes, and had a mission.